192 related articles for article (PubMed ID: 6214377)
1. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
Rapaport M; Puhvel SM; Reisner RM
Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
Puhvel SM
Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
[TBL] [Abstract][Full Text] [Related]
3. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
4. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
Thomas DR; Raimer S; Smith EB
Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of a new erythromycin solution for acne vulgaris.
Rivkin L; Rapaport M
Cutis; 1980 May; 25(5):552-5. PubMed ID: 6445816
[TBL] [Abstract][Full Text] [Related]
6. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
Resh W; Stoughton RB
Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
8. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
Stoughton RB; Cornell RC; Gange RW; Walter JF
Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
10. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
[TBL] [Abstract][Full Text] [Related]
11. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition.
Strauss JS; Stranieri AM
J Am Acad Dermatol; 1984 Jul; 11(1):86-9. PubMed ID: 6234335
[TBL] [Abstract][Full Text] [Related]
12. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
Gloor M; Lamerz A; Franke-Hoffman M
Zentralbl Bakteriol A; 1981 Feb; 248(4):502-8. PubMed ID: 6452774
[TBL] [Abstract][Full Text] [Related]
13. [Comparative double blind study of topical clindamycine phosphate, oral tetracycline chlorhydrate and a placebo in the treatment of moderate to severe acne vulgaris].
Guertin-Larochelle S; Raymond GP; Gratton D; Collins JP; Gaudreau P
Union Med Can; 1982 Jun; 111(6):559-62. PubMed ID: 6214069
[No Abstract] [Full Text] [Related]
14. Comparative efficacy of oral erythromycin versus oral tetracycline in the treatment of acne vulgaris. A double-blind study.
Gammon WR; Meyer C; Lantis S; Shenefelt P; Reizner G; Cripps DJ
J Am Acad Dermatol; 1986 Feb; 14(2 Pt 1):183-6. PubMed ID: 2936772
[TBL] [Abstract][Full Text] [Related]
15. Topical erythromycin vs blank vehicle in a multiclinic acne study.
Jones EL; Crumley AF
Arch Dermatol; 1981 Sep; 117(9):551-3. PubMed ID: 6457568
[TBL] [Abstract][Full Text] [Related]
16. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris.
Borglund E; Hägermark O; Nord CE
Scand J Infect Dis Suppl; 1984; 43():76-81. PubMed ID: 6242074
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial.
Ozolins M; Eady EA; Avery AJ; Cunliffe WJ; Po AL; O'Neill C; Simpson NB; Walters CE; Carnegie E; Lewis JB; Dada J; Haynes M; Williams K; Williams HC
Lancet; 2004 Dec 18-31; 364(9452):2188-95. PubMed ID: 15610805
[TBL] [Abstract][Full Text] [Related]
18. Topical erythromycin with zinc in acne. A double-blind controlled study.
Feucht CL; Allen BS; Chalker DK; Smith JG
J Am Acad Dermatol; 1980 Nov; 3(5):483-91. PubMed ID: 6452464
[TBL] [Abstract][Full Text] [Related]
19. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
20. Erythromycin 2 percent gel in the treatment of acne vulgaris.
Pochi PE; Bagatell FK; Ellis CN; Stoughton RB; Whitmore CG; Saatjian GD; Sefton J
Cutis; 1988 Feb; 41(2):132-6. PubMed ID: 2964344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
